Latest News

Chemo-radionuclide therapy halts neuroendocrine cancer

Advanced cancer of the neuroendocrine system can lead to dismal prognoses, but a novel therapy is packing a punch by uniting powerful radionuclide treatment and chemotherapy drugs, revealed researchers. Neuroendocrine tumors (NETs) are those that develop within a multiplicity of organs throughout the body that have nerve cells and interact with the endocrine system through chemical signaling made possible with various hormones. These tumors usually develop along the intestines and lungs, but they can also be found in the pancreas and many other sites.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Pregnancy and PTSD: Surprising findings could help moms-to-be at risk

  • Baby physics

  • Couch potatoes may have smaller brains later in life

  • Your brain may be what interests that guy checking you out

  • Remember where you're going? How scent helps

  • Task-oriented rehab program does not result in greater recovery from stroke

  • Study sheds light on source of drug addicts risk-taking behavior

  • Exercise and meditation together help beat depression

  • Overconfidence, loss aversion are key predictors for investment mistakes

  • Two in five individuals with schizophrenia have attempted suicide

  •